Organoids have extensive therapeutic potential and are increasingly opening up new avenues within regenerative medicine. However, their clinical application is greatly limited by the lack of effective GMP-compliant systems for organoid expansion in culture. Here, we envisage that the use of extracellular matrix (ECM) hydrogels derived from decellularized tissues (DT) can provide an environment capable of directing cell growth. These gels possess the biochemical signature of tissue-specific ECM and have the potential for clinical translation. Gels from decellularized porcine small intestine (SI) mucosa/submucosa enable formation and growth of endoderm-derived human organoids, such as gastric, hepatic, pancreatic, and SI. ECM gels can be used as a tool for direct human organoid derivation, for cell growth with a stable transcriptomic signature, and for in vivo organoid delivery. The development of these ECM-derived hydrogels opens up the potential for human organoids to be used clinically.
Despite the tremendous technical advancements in 3D bioprinting, the concept of fabricating 3D structures and functional tissues directly in live animals remains a visionary challenge. We show that 3D cell-laden hydrogels can be efficiently bioprinted across tissues and within tissues of living animals.We developed photo-sensitive polymers that allow in vitro and in vivo fabrication of hydrogels into pre-existing structures, by bio-orthogonal two-photon cycloaddition and crosslinking at wavelengths longer than 850 nm, without byproducts. By this technique, that we name intravital 3D bioprinting, after injection of these polymers in vivo it is possible to fabricate complex 3D structures inside tissues of living mice, including the dermis across epidermis, the skeletal muscle across epimysium or the brain across meninges. The use of commonly available multi-photon microscopes allows accurate (XYZ) positioning and orientation of bioprinted structures into specific anatomical sites. Finally, we show that intravital 3D bioprinting of donor muscle-derived stem cells allows de novo formation of myofibers in host animals. We envision that this strategy will offer an alternative in vivo approach to conventional bioprinting technology, holding great promises to substantially change the paradigm of 3D bioprinting for pre-clinical and clinical use.
Metastatic breast cancer cells disseminate to organs with a soft microenvironment. Whether and how local tissue mechanical properties influence their response to treatment remains unclear. Here we found that a soft ECM empowers redox homeostasis. Cells cultured on a soft ECM display increased peri-mitochondrial F-actin promoted by Spire1C and Arp2/3 nucleation factors, and increased DRP1- and MIEF1/2-dependent mitochondrial fission. Changes in mitochondrial dynamics lead to increased mtROS production and activate the NRF2 antioxidant transcriptional response, including increased cystine uptake and glutathione metabolism. This retrograde response endows cells with resistance to oxidative stress and ROS-dependent chemotherapy drugs. This is relevant in a mouse model of metastatic breast cancer cells dormant in the lung soft tissue, where inhibition of DRP1 and NRF2 restored cisplatin sensitivity and prevented disseminated cancer cell awakening. We propose that targeting this mitochondrial dynamics- and redox-based mechanotransduction pathway could open avenues to prevent metastatic relapse.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.